Cargando…
mRNA lipid nanoparticle-mediated pyroptosis sensitizes immunologically cold tumors to checkpoint immunotherapy
Synergistically improving T-cell responsiveness is promising for favorable therapeutic outcomes in immunologically cold tumors, yet current treatments often fail to induce a cascade of cancer-immunity cycle for effective antitumor immunity. Gasdermin-mediated pyroptosis is a newly discovered mechani...
Autores principales: | Li, Fengqiao, Zhang, Xue-Qing, Ho, William, Tang, Maoping, Li, Zhongyu, Bu, Lei, Xu, Xiaoyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349854/ https://www.ncbi.nlm.nih.gov/pubmed/37454146 http://dx.doi.org/10.1038/s41467-023-39938-9 |
Ejemplares similares
-
Targeted delivery of a STING agonist to brain tumors using bioengineered protein nanoparticles for enhanced immunotherapy
por: Wang, Bin, et al.
Publicado: (2022) -
Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition
por: Voeller, Julie, et al.
Publicado: (2019) -
Lipid Nanoparticles for mRNA Delivery to Enhance Cancer Immunotherapy
por: Wang, Hong-Li, et al.
Publicado: (2022) -
Advances in Lipid Nanoparticles for mRNA-Based Cancer Immunotherapy
por: Guevara, Maria L., et al.
Publicado: (2020) -
Polysarcosine-Functionalized mRNA Lipid Nanoparticles Tailored for Immunotherapy
por: Wilhelmy, Christoph, et al.
Publicado: (2023)